Heidelberg Materials UK is carrying out trials using CarbonCure technology in ready-mixed concrete, for the first time in England, at its Greenwich concrete plant.
The process involves injecting pure manufactured CO₂ into fresh concrete to improve hydration. This allows producers to use an average of five per cent less cement within the concrete.
Concrete technical director, Daniel Clayton, says; “The CarbonCure trial is the first of its kind to trial the technology in ready-mix concrete in England and is another example of our commitment to innovation and decarbonising our business, to deliver lower carbon construction materials to our customers.
“We’re continuing to invest in a range of innovative technologies to enable this, including partnering with CarbonCure in this trial where the mineralised CO₂ within the concrete stays permanently locked in, even if the concrete is demolished at some point in the future.”
Source:www.buildersmerchantsjournal.net
The research firm Jefferies has raised its price target for Heidelberg Materials from €245.20 to €300 and maintained its "buy" rating. The building materials group also remains the industry favorite of expert Glynis Johnson in her outlook for 2026 published on Tuesday evening. She believes that Heidelberg has a number of levers for profit potential that are likely to continue the revaluation story. However, she sees the greatest overall price potential in Saint Gobain.
Source: www.marketscreener.com
Aleksei Andrievskii is the founder of the ANDRIEVSKII SEA WEALTH family office in Cyprus, a member of the advisory board at Bendura Bank AG, Liechtenstein